Formula1.jpg (Formula1)
Chemical structure of methylprednisolone sodium succinate, the active ingredient in Solu-Medrol injection powder for solution.*
Solu-medrol Injection, Powder, For Solution
Product Images NDC 0404-9957
7 FDA label images from Henry Schein, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Solu-medrol (NDC 0404-9957). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image1.jpg (Image1)
The table lists preservative-free formulations of methylprednisolone sodium succinate in Act-O-Vial single-dose vials. It details the concentration per vial size, including 40 mg/mL, 125 mg/2 mL, 500 mg/4 mL, and 1 gram/8 mL, along with associated amounts of monobasic sodium phosphate anhydrous and dibasic sodium phosphate dried, plus lactose hydrous for the 40 mg formulation.*
Image2.jpg (Image2)
A table detailing formulations of methylprednisolone sodium succinate preserved with benzyl alcohol. It lists four vial types: 500 mg, 1 gram, 2 gram, and 2 gram with diluent. Each entry specifies volume when mixed, amounts of methylprednisolone sodium succinate equivalent, monobasic sodium phosphate anhydrous, and dibasic sodium phosphate dried. It notes recommended diluent contains benzyl alcohol as preservative.*
Image3.jpg (Image3)
A text panel emphasizing the use of only the accompanying diluent or bacteriostatic water with benzyl alcohol when reconstituting Solu-Medrol, with a warning to use the solution within 48 hours after mixing.*
Image4.jpg (Image4)
A data table comparing equivalent milligram dosages of various glucocorticoids, including Cortisone, Hydrocortisone, Prednisolone, Prednisone, Methylprednisolone, Triamcinolone, Paramethasone, Betamethasone, and Dexamethasone, with additional explanatory text about dose relationships for oral or intravenous versus intramuscular or joint space administration.*
Image5.jpg (Image5)
An illustration showing a cross-sectional view of a vial stopper being penetrated by a needle, depicting the mechanism of needle insertion through the vial closure for drug withdrawal.*
Label1.jpg (Label1)
Solu-Medrol 125 mg/2 mL vial label for methylprednisolone sodium succinate injection powder for solution. Single-dose vial for intramuscular or intravenous use, preservative-free, packaged by Henry Schein, Inc. Label includes storage instructions, barcode, and placeholders for lot number and expiration date.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
